CDFR0612

CDFR0612 is an investigational drug developed for bowel cleansing prior to colonoscopy. It has been evaluated in clinical trials alongside a related formulation, CDFR0613, and compared to standard preparations such as polyethylene glycol plus picosulfate (Coolprep Powder). The drug is administered as a solution mixed with water and taken orally before the procedure. Its primary indication is for colonic diseases requiring bowel preparation, specifically to ensure effective cleansing of the colon prior to endoscopic examination. The mechanism of action and specific active ingredients have not been disclosed in public sources; however, it functions as a bowel cleansing agent[1][2][3][5].